Successful spinal fusion by E. coli-derived BMP-2-adsorbed porous β-TCP granules: A pilot study

Clinical Orthopaedics and Related Research

Volumn 467, Issue 12, 2009, Pages 3206-3212

  Dohzono, Sho ^a   Imai, Yuuki ^a   Nakamura, Hiroaki ^a   Wakitani, Shigeyuki ^a   Takaoka, Kunio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; ESCHERICHIA COLI DERIVED RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOMECHANICS; BONE GRAFT; BONE REGENERATION; BONE REMODELING; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG GRANULE; EXPERIMENTAL MODEL; HISTOLOGY; LUMBAR SPINE; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; RABBIT; SPINE FUSION; THREE DIMENSIONAL IMAGING;

EID: 70449532196     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-009-0960-1     Document Type: Conference Paper

References (46)

1. T Akamaru D Suh SD Boden HS Kim A Minamide J Louis-Ugbo 2003 Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion Spine. 28 429 434 10.1097/00007632-200303010-00004 12616152 (Pubitemid 36330828)
2. RT Allen YP Lee E Stimson SR Garfin 2007 Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis Spine. 32 2996 3006 10.1097/BRS.0b013e31815cde3e 18091493 (Pubitemid 350307283)
3. OA Arosarena WL Collins 2005 Bone regeneration in the rat mandible with bone morphogenetic protein-2: a comparison of two carriers Otolaryngol Head Neck Surg. 132 592 597 10.1016/j.otohns.2004.09.137 15806052 (Pubitemid 40460890)
4. ED Arrington WJ Smith HG Chambers AL Bucknell NA Davino 1996 Complications of iliac crest bone graft harvesting Clin Orthop Relat Res. 329 300 309 10.1097/00003086-199608000-00037 8769465
5. SD Boden J Kang H Sandhu JG Heller 2002 Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine. 27 2662 2673 10.1097/00007632-200212010-00005 12461392 (Pubitemid 35425320)
6. SD Boden JH Schimandle WC Hutton 1995 An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics Spine. 20 412 420 1:STN:280: DyaK2M3ms1SgtA%3D%3D 7747224
7. SM David HE Gruber RA Meyer Jr T Murakami OB Tabor BA Howard JM Wozney EN Hanley Jr 1999 Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers Spine. 24 1973 1979 10.1097/00007632-199910010-00002 1:STN:280:DyaK1MvlslKktQ%3D%3D 10528370 (Pubitemid 29480466)
8. JR Dimar SD Glassman KJ Burkus LY Carreon 2006 Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft Spine. 31 2534 2539 10.1097/01.brs.0000240715. 78657.81 17047540 discussion 2540 (Pubitemid 44632234)
9. SD Glassman JR Dimar 3rd K Burkus JW Hardacker PW Pryor SD Boden LY Carreon 2007 The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers Spine. 32 1693 1698 10.1097/BRS.0b013e318074c366 17621221 (Pubitemid 47051857)
10. S Govender C Csimma HK Genant A Valentin-Opran Y Amit R Arbel H Aro D Atar M Bishay MG Borner P Chiron P Choong J Cinats B Courtenay R Feibel B Geulette C Gravel N Haas M Raschke E Hammacher D van der Velde P Hardy M Holt C Josten RL Ketterl B Lindeque G Lob H Mathevon G McCoy D Marsh R Miller E Munting S Oevre L Nordsletten A Patel A Pohl W Rennie P Reynders PM Rommens J Rondia WC Rossouw PJ Daneel S Ruff A Ruter S Santavirta TA Schildhauer C Gekle R Schnettler D Segal H Seiler RB Snowdowne J Stapert G Taglang R Verdonk L Vogels A Weckbach A Wentzensen T Wisniewski 2002 Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients J Bone Joint Surg Am. 84 2123 2134 10.1302/0301-620X.84B5.12795 12473698
11. JN Grauer TC Patel JS Erulkar NW Troiano MM Panjabi GE Friedlaender 2001 2000 Young Investigator Research Award winner. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion Spine 26 127 133 10.1097/00007632-200101150-00004 1:STN:280:DC%2BD3M7lsV2iuw%3D%3D 11154530 (Pubitemid 32115601)
12. M Hoshino T Namikawa M Kato H Terai S Taguchi K Takaoka 2007 Repair of bone defects in revision hip arthroplasty by implantation of a new bone-inducing material comprised of recombinant human BMP-2, Beta-TCP powder, and a biodegradable polymer: an experimental study in dogs J Orthop Res. 25 1042 1051 10.1002/jor.20424 1:CAS:528:DC%2BD2sXovFKitLg%3D 17469187 (Pubitemid 47233080)
13. WK Hsu JC Wang 2008 The use of bone morphogenetic protein in spine fusion Spine J. 8 419 425 10.1016/j.spinee.2008.01.008 18375186
14. H Itoh S Ebara M Kamimura Y Tateiwa T Kinoshita Y Yuzawa K Takaoka 1999 Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2 Spine. 24 1402 1405 10.1097/00007632-199907150-00003 1:STN:280:DyaK1Mzlt1GrsA%3D%3D 10423783 (Pubitemid 29331411)
15. R Johnsson B Stromqvist P Aspenberg 2002 Randomized radiostereometric study comparing osteogenic protein-1 (BMP-7) and autograft bone in human noninstrumented posterolateral lumbar fusion: 2002 Volvo Award in clinical studies Spine. 27 2654 2661 10.1097/00007632-200212010-00004 12461391 (Pubitemid 35425319)
16. V Joseph YR Rampersaud 2007 Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis Spine. 32 2885 2890 10.1097/BRS.0b013e31815b7596 18246013 (Pubitemid 351339361)
17. S Konishi H Nakamura M Seki R Nagayama Y Yamano 2002 Hydroxyapatite granule graft combined with recombinant human bone morphogenic protein-2 for solid lumbar fusion J Spinal Disord Tech. 15 237 244 12131427
18. NR Kubler JF Reuther G Faller T Kirchner R Ruppert W Sebald 1998 Inductive properties of recombinant human BMP-2 produced in a bacterial expression system Int J Oral Maxillofac Surg. 27 305 309 10.1016/S0901-5027(05) 80621-6 1:STN:280:DyaK1czmtFKntQ%3D%3D 9698181
19. LT Kurz SR Garfin RE Booth Jr 1989 Harvesting autogenous iliac bone grafts. A review of complications and techniques Spine. 14 1324 1331 10.1097/00007632-198912000-00009 1:STN:280:DyaK3c7ktVykuw%3D%3D 2617362 (Pubitemid 20036764)
20. KU Lewandrowski C Nanson R Calderon 2007 Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases Spine J. 7 609 614 10.1016/j.spinee.2007.01. 011 17526434 (Pubitemid 47471438)
21. GJ Martin Jr SD Boden MA Marone MA Marone PA Moskovitz 1999 Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety J Spinal Disord. 12 179 186 10382769
22. A Minamide M Kawakami H Hashizume R Sakata T Tamaki 2001 Evaluation of carriers of bone morphogenetic protein for spinal fusion Spine. 26 933 939 10.1097/00007632-200104150-00017 1:STN:280:DC%2BD3MzhsVCqtQ%3D%3D 11317116 (Pubitemid 32373980)
23. A Minamide M Kawakami H Hashizume R Sakata M Yoshida T Tamaki 2004 Experimental study of carriers of bone morphogenetic protein used for spinal fusion J Orthop Sci. 9 142 151 10.1007/s00776-003-0749-0 1:CAS:528: DC%2BD2cXisVWgtro%3D 15045542 (Pubitemid 38506738)
24. K Nakagawa Y Imai Y Ohta K Takaoka 2007 Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation Bone. 41 543 548 10.1016/j.bone.2007.06.013 1:CAS:528:DC%2BD2sXhtVCgtr7J 17681894 (Pubitemid 47385438)
25. T Namikawa H Terai M Hoshino M Kato H Toyoda K Yano H Nakamura K Takaoka 2007 Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model Spine. 32 2294 2299 10.1097/BRS.0b013e318154c5b6 17906568 (Pubitemid 47508834)
26. T Namikawa H Terai E Suzuki M Hoshino H Toyoda H Nakamura S Miyamoto N Takahashi T Ninomiya K Takaoka 2005 Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model Spine. 30 1717 1722 10.1097/01.brs.0000172155.17239.fa 16094272 (Pubitemid 41099484)
27. Y Ohta K Nakagawa Y Imai T Katagiri T Koike K Takaoka 2008 Cyclic AMP enhances Smad-mediated BMP signaling through PKA-CREB pathway J Bone Miner Metab. 26 478 484 1:CAS:528:DC%2BD1cXhtVGnsL7O 18758906
28. LG Raisz 2005 Pathogenesis of osteoporosis: concepts, conflicts, and prospects J Clin Invest. 115 3318 3325 10.1172/JCI27071 1:CAS:528: DC%2BD2MXhtlSqtLzJ 16322775 (Pubitemid 43121814)
29. R Ruppert E Hoffmann W Sebald 1996 Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity Eur J Biochem. 237 295 302 10.1111/j.1432-1033.1996.0295n.x 1:CAS:528: DyaK28Xitlyisrg%3D 8620887
30. N Saito T Okada H Horiuchi N Murakami J Takahashi M Nawata H Ota K Nozaki K Takaoka 2001 A biodegradable polymer as a cytokine delivery system for inducing bone formation Nat Biotechnol. 19 332 335 10.1038/86715 1:CAS:528:DC%2BD3MXis1Smsb8%3D 11283590 (Pubitemid 32275341)
31. HS Sandhu LE Kanim JM Kabo JM Toth EN Zeegen D Liu RB Delamarter EG Dawson 1996 Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion Spine. 21 2115 2122 10.1097/00007632-199609150-00012 1:STN:280:DyaK2s%2FkvVKjtw%3D%3D 8893436 (Pubitemid 26330597)
32. BG Santoni GE Pluhar T Motta DL Wheeler 2007 Hollow calcium phosphate microcarriers for bone regeneration: in vitro osteoproduction and ex vivo mechanical assessment Biomed Mater Eng. 17 277 289 1:CAS:528: DC%2BD2sXpslarsL4%3D 17851170
33. R Sasaoka H Terai H Toyoda Y Imai R Sugama K Takaoka 2004 A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2 Biochem Biophys Res Commun. 318 704 709 10.1016/j.bbrc.2004.04.080 1:CAS:528:DC%2BD2cXktV2msbc%3D 15144895 (Pubitemid 38624211)
34. JH Schimandle SD Boden WC Hutton 1995 Experimental spinal fusion with recombinant human bone morphogenetic protein-2 Spine. 20 1326 1337 1:STN:280:DyaK2Mvgs1OksA%3D%3D 7676329
35. HJ Seeherman M Bouxsein H Kim R Li XJ Li M Aiolova JM Wozney 2004 Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model J Bone Joint Surg Am. 86 1961 1972 15342759
36. S Taguchi T Namikawa M Ieguchi K Takaoka 2007 Reconstruction of bone defects using rhBMP-2-coated devitalized bone Clin Orthop Relat Res. 461 162 169 17414161
37. H Takayanagi 2007 Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems Nat Rev Immunol. 7 292 304 10.1038/nri2062 1:CAS:528:DC%2BD2sXjtlyhurc%3D 17380158 (Pubitemid 46480961)
38. H Toyoda H Terai R Sasaoka K Oda K Takaoka 2005 Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist Bone. 37 555 562 10.1016/j.bone.2005.04.042 1:CAS:528:DC%2BD2MXhtVWgtrvN 16027058 (Pubitemid 41317328)
39. MR Urist 1965 Bone: formation by autoinduction Science. 150 893 899 10.1126/science.150.3698.893 1:STN:280:DyaF28%2FhvFekuw%3D%3D 5319761
40. U Weigel M Meyer W Sebald 1989 Mutant proteins of human interleukin 2. Renaturation yield, proliferative activity and receptor binding Eur J Biochem. 180 295 300 10.1111/j.1432-1033.1989.tb14647.x 1:CAS:528:DyaL1MXhtlegtr8%3D 2647490 (Pubitemid 19088817)
41. DA Wong A Kumar S Jatana G Ghiselli K Wong 2007 Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2) Spine J. 8 1011 1018 10.1016/j.spinee.2007.06.014 18037352
42. JM Wozney V Rosen AJ Celeste LM Mitsock MJ Whitters RW Kriz RM Hewick EA Wang 1988 Novel regulators of bone formation: molecular clones and activities Science. 242 1528 1534 10.1126/science.3201241 1:CAS:528:DyaL1MXkvFantr8%3D 3201241
43. CH Wu K Hara H Ozawa 1992 Enhanced osteoinduction by intramuscular grafting of BMP-beta-TCP compound pellets into murine models Arch Histol Cytol. 55 97 112 10.1679/aohc.55.97 1:CAS:528:DyaK3sXitF2rsr8%3D 1586574
44. Y Yamamoto N Udagawa S Matsuura Y Nakamichi H Horiuchi A Hosoya M Nakamura H Ozawa K Takaoka JM Penninger T Noguchi N Takahashi 2006 Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand Endocrinology. 147 3366 3374 10.1210/en.2006-0216 1:CAS:528:DC%2BD28XmtlOrs7s%3D 16627581 (Pubitemid 43901128)
45. K Yano M Hoshino Y Ohta T Manaka Y Naka Y Imai W Sebald K Takaoka 2009 Osteoinductive capacity and heat stability of recombinant human bone morphogenetic protein-2 produced by Escherichia coli and dimerized by biochemical processing J Bone Miner Metab. 27 355 363 10.1007/s00774-009-0040-3 1:CAS:528:DC%2BD1MXksF2iu7Y%3D 19229473
46. M Zaidi 2007 Skeletal remodeling in health and disease Nat Med. 13 791 801 10.1038/nm1593 1:CAS:528:DC%2BD2sXnsFWmtro%3D 17618270 (Pubitemid 47038187)